gemcitabine has been researched along with Cystitis in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (60.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Cheng, W; Chu, X; Huang, S; Zheng, H; Zheng, X; Zhou, Y | 1 |
Altug, T; Atalar, B; Dinçbaş, FO; Gedik, N; Ilvan, S; Koca, S; Oksüz, DC; Ozel, S | 1 |
Brausi, M; Fiorito, C; Gontero, P; Oderda, M; Pappagallo, G | 1 |
Freiha, F; Morgan, K; Srinivas, S | 1 |
Aronson, M; Dalal, E; Laufer, M; Nativ, O; Sabo, E | 1 |
1 review(s) available for gemcitabine and Cystitis
Article | Year |
---|---|
Effect of intravesical mitomycin compared with gemcitabine on the treatment non-muscle invasive bladder cancer: A meta-analysis.
Topics: Administration, Intravesical; Cystitis; Deoxycytidine; Gemcitabine; Hematuria; Humans; Mitomycin; Non-Muscle Invasive Bladder Neoplasms; Urinary Bladder Neoplasms | 2023 |
1 trial(s) available for gemcitabine and Cystitis
Article | Year |
---|---|
Phase II study of biweekly gemcitabine as first line therapy in CIS of the bladder: what does an aborted trial tell us?
Topics: Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Carcinoma in Situ; Cystitis; Deoxycytidine; Drug Administration Schedule; Female; Gemcitabine; Humans; Leukopenia; Male; Middle Aged; Remission Induction; Survival Analysis; Treatment Outcome; Urinary Bladder Neoplasms | 2013 |
3 other study(ies) available for gemcitabine and Cystitis
Article | Year |
---|---|
The role of amifostine on late normal tissue damage induced by pelvic radiotherapy with concomitant gemcitabine: an in vivo study.
Topics: Amifostine; Animals; Colitis; Collagen; Combined Modality Therapy; Cystitis; Deoxycytidine; Fibrosis; Gemcitabine; Male; Neoplasm Staging; Pelvic Neoplasms; Radiation-Protective Agents; Radiotherapy Dosage; Rats; Rats, Wistar; Ribonucleotide Reductases; Survival Rate; Treatment Outcome | 2009 |
Synchronous solitary metastasis of transitional cell carcinoma of the bladder to the testis.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Cystectomy; Cystitis; Deoxycytidine; Gemcitabine; Hematuria; Humans; Incidental Findings; Male; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Orchiectomy; Positron-Emission Tomography; Prostatectomy; Prostatic Neoplasms; Radiation Injuries; Testicular Neoplasms; Transurethral Resection of Prostate; Ultrasonography; Urinary Bladder Neoplasms; Urinary Diversion | 2004 |
Antineoplastic effect of gemcitabine in an animal model of superficial bladder cancer.
Topics: Administration, Intravesical; Animals; Antimetabolites, Antineoplastic; Carcinoma, Transitional Cell; Cystitis; Deoxycytidine; Drug Screening Assays, Antitumor; Female; Fibrosis; Gemcitabine; Hyperplasia; Injections, Intraperitoneal; Mice; Mice, Inbred C3H; Neoplasm Transplantation; Organ Size; Single-Blind Method; Urinary Bladder Neoplasms; Urothelium | 2004 |